Universal Health Services Cash & Equivalents Growth & History (UHS)
Universal Health Services's cash and equivalents was $137.8M for fiscal 2025.
View full Universal Health Services company overviewUniversal Health Services annual cash and equivalents history
| Fiscal year | Period ended | Cash and equivalents | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $137.8M | $11.8M | +9.38% |
| 2024 | 2024-12-31 | $126.0M | $6.5M | +5.48% |
| 2023 | 2023-12-31 | $119.4M | $16.6M | +16.17% |
| 2022 | 2022-12-31 | $102.8M | −$12.5M | −10.83% |
| 2021 | 2021-12-31 | $115.3M | −$1.11B | −90.58% |
| 2020 | 2020-12-31 | $1.22B | $1.16B | +1898.58% |
| 2019 | 2019-12-31 | $61.3M | −$44.0M | −41.77% |
| 2018 | 2018-12-31 | $105.2M | $30.8M | +41.38% |
| 2017 | 2017-12-31 | $74.4M | $40.7M | +120.53% |
| 2016 | 2016-12-31 | $33.7M | −$27.5M | −44.88% |
| 2015 | 2015-12-31 | $61.2M | $29.2M | +90.93% |
| 2014 | 2014-12-31 | $32.1M | $14.8M | +86.04% |
| 2013 | 2013-12-31 | $17.2M | −$6.2M | −26.56% |
| 2012 | 2012-12-31 | $23.5M | −$17.8M | −43.07% |
| 2011 | 2011-12-31 | $41.2M | $11.8M | +39.88% |
| 2010 | 2010-12-31 | $29.5M | $20.3M | +221.07% |
| 2009 | 2009-12-31 | $9.2M | $3.7M | +68.13% |
| 2008 | 2008-12-31 | $5.5M | — | — |
Universal Health Services quarterly cash and equivalents
| Fiscal quarter | Period ended | Cash and equivalents | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $138.8M | $1.2M | +0.88% |
| Q1 2026 | 2026-03-31 | $119.0M | −$7.7M | −6.09% |
| Q4 2025 | 2025-12-31 | $137.8M | $11.8M | +9.38% |
| Q3 2025 | 2025-09-30 | $112.9M | $6.8M | +6.43% |
| Q2 2025 | 2025-06-30 | $137.6M | $8.8M | +6.84% |
| Q1 2025 | 2025-03-31 | $126.8M | $14.7M | +13.08% |
| Q4 2024 | 2024-12-31 | $126.0M | $6.5M | +5.48% |
| Q3 2024 | 2024-09-30 | $106.1M | $25.3M | +31.34% |
| Q2 2024 | 2024-06-30 | $128.8M | $49.3M | +62.09% |
| Q1 2024 | 2024-03-31 | $112.1M | $2.1M | +1.93% |
| Q4 2023 | 2023-12-31 | $119.4M | $16.6M | +16.17% |
| Q3 2023 | 2023-09-30 | $80.8M | $6.2M | +8.31% |
| Q2 2023 | 2023-06-30 | $79.5M | −$53.2M | −40.11% |
| Q1 2023 | 2023-03-31 | $110.0M | $4.0M | +3.75% |
| Q4 2022 | 2022-12-31 | $102.8M | −$12.5M | −10.83% |
| Q3 2022 | 2022-09-30 | $74.6M | −$115.2M | −60.70% |
| Q2 2022 | 2022-06-30 | $132.7M | −$66.4M | −33.34% |
| Q1 2022 | 2022-03-31 | $106.0M | −$658.5M | −86.13% |
| Q4 2021 | 2021-12-31 | $115.3M | −$1.11B | −90.58% |
| Q3 2021 | 2021-09-30 | $189.7M | −$911.5M | −82.77% |
| Q2 2021 | 2021-06-30 | $199.0M | −$340.6M | −63.12% |
| Q1 2021 | 2021-03-31 | $764.5M | $709.9M | +1299.70% |
| Q4 2020 | 2020-12-31 | $1.22B | $1.16B | +1898.58% |
| Q3 2020 | 2020-09-30 | $1.10B | $1.04B | +1769.50% |
| Q2 2020 | 2020-06-30 | $539.6M | $478.3M | +780.34% |
| Q1 2020 | 2020-03-31 | $54.6M | −$8.1M | −12.92% |
| Q4 2019 | 2019-12-31 | $61.3M | −$44.0M | −41.77% |
| Q3 2019 | 2019-09-30 | $58.9M | −$24.8M | −29.64% |
| Q2 2019 | 2019-06-30 | $61.3M | −$15.6M | −20.28% |
| Q1 2019 | 2019-03-31 | $62.7M | −$10.3M | −14.14% |
| Q4 2018 | 2018-12-31 | $105.2M | $30.8M | +41.38% |
| Q3 2018 | 2018-09-30 | $83.7M | $18.3M | +27.97% |
| Q2 2018 | 2018-06-30 | $76.9M | $10.4M | +15.71% |
| Q1 2018 | 2018-03-31 | $73.1M | $10.1M | +16.01% |
| Q4 2017 | 2017-12-31 | $74.4M | $40.7M | +120.53% |
| Q3 2017 | 2017-09-30 | $65.4M | $3.7M | +5.96% |
| Q2 2017 | 2017-06-30 | $66.4M | $10.2M | +18.08% |
| Q1 2017 | 2017-03-31 | $63.0M | $8.4M | +15.36% |
| Q4 2016 | 2016-12-31 | $33.7M | −$27.5M | −44.88% |
| Q3 2016 | 2016-09-30 | $61.7M | $22.2M | +56.22% |
| Q2 2016 | 2016-06-30 | $56.3M | $13.8M | +32.52% |
| Q1 2016 | 2016-03-31 | $54.6M | $19.5M | +55.62% |
| Q4 2015 | 2015-12-31 | $61.2M | $29.2M | +90.93% |
| Q3 2015 | 2015-09-30 | $39.5M | −$188,000 | −0.47% |
| Q2 2015 | 2015-06-30 | $42.5M | $27.7M | +188.24% |
| Q1 2015 | 2015-03-31 | $35.1M | $18.8M | +115.72% |
| Q4 2014 | 2014-12-31 | $32.1M | $14.8M | +86.04% |
| Q3 2014 | 2014-09-30 | $39.7M | $27.6M | +227.59% |
| Q2 2014 | 2014-06-30 | $14.7M | $2.2M | +17.31% |
| Q1 2014 | 2014-03-31 | $16.3M | −$1.1M | −6.52% |
| Q4 2013 | 2013-12-31 | $17.2M | −$6.2M | −26.56% |
| Q3 2013 | 2013-09-30 | $12.1M | −$13.5M | −52.74% |
| Q2 2013 | 2013-06-30 | $12.6M | −$20.4M | −61.88% |
| Q1 2013 | 2013-03-31 | $17.4M | −$24.6M | −58.58% |
| Q4 2012 | 2012-12-31 | $23.5M | −$17.8M | −43.07% |
| Q3 2012 | 2012-09-30 | $25.7M | −$13.5M | −34.47% |
| Q2 2012 | 2012-06-30 | $32.9M | −$1.9M | −5.39% |
| Q1 2012 | 2012-03-31 | $42.0M | −$10.1M | −19.35% |
| Q4 2011 | 2011-12-31 | $41.2M | $11.8M | +39.88% |
| Q3 2011 | 2011-09-30 | $39.1M | $29.5M | +306.55% |
| Q2 2011 | 2011-06-30 | $34.8M | $22.5M | +182.21% |
| Q1 2011 | 2011-03-31 | $52.1M | — | — |
| Q4 2010 | 2010-12-31 | $29.5M | $20.3M | +221.07% |
| Q3 2010 | 2010-09-30 | $9.6M | — | — |
| Q2 2010 | 2010-06-30 | $12.3M | — | — |
| Q4 2009 | 2009-12-31 | $9.2M | — | — |
Universal Health Services cash and equivalents trends
Over the last five fiscal years, Universal Health Services's cash and equivalents decreased from $1.22B to $137.8M, a change of −$1.09B. The latest reported quarter, Q2 2026, shows $138.8M.
What cash and equivalents mean
Cash and cash equivalents, often described as cash on hand, are highly liquid resources available for near-term obligations, investment, acquisitions, debt repayment, dividends, or share repurchases. This measure does not include short-term investments reported separately.
Reported cash and equivalents
TickerStat standardizes cash and cash equivalents reported on the balance sheet. Restricted cash is included only when the company reports it within the selected consolidated cash concept. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Universal Health Services source filings ↗